A multicenter study of the clinical performance of the Ortho Gyne-T380 Slimline intrauterine device in routine use in general practice and family planning clinics

1993 ◽  
Vol 9 (1) ◽  
pp. 59-64 ◽  
Author(s):  
Keyword(s):  
General Practice ◽  
Family Planning ◽  
Multicenter Study ◽  
Clinical Performance ◽  
Intrauterine Device

scholarly journals Prevalence of Postpartum Family Planning Service Coverage in Selected Referral Facilities of Nepal

2020 ◽  
Vol 58 (221) ◽  
Author(s):  
Kusum Thapa ◽  
Rolina Dhital ◽  
Sameena Rajbhandari ◽  
Shikha Thapa ◽  
Sabina Pokhrel ◽  
...  
Keyword(s):  
Family Planning ◽  
Intrauterine Device ◽  
Cross Sectional Study ◽  
Planning Method ◽  
Family Planning Method ◽  
Postpartum Contraception ◽  
Cross Sectional ◽  
Postpartum Family Planning ◽  
Ethical Approval ◽  
Service Coverage

Introduction: Nepal Society of Obstetricians and Gynecologists jointly with the Nepalese governmentand with the support from the International Federation of Obstetrics and Gynecology hasimplemented an initiative to institutionalize postpartum family planning services in selected majorreferral facilities of Nepal to address the gap of low uptake of postpartum family planning in Nepal.The aim of the study is to find the prevalence of the service coverage of postpartum contraception inthe selected facilities. Methods: A descriptive cross-sectional study was conducted in seven major referral facilities acrossNepal. Data were collected from the hospital records of all women who delivered in these facilitiesbetween October 2018 and March 2019. Ethical approval for this study was obtained from NepalHealth Research Council. Data analysis was done with SPSS version 23. Results: Among the 29,072 deliveries from all the facilities, postpartum family planning counselingcoverage was 27,301 (93.9%). The prevalence of uptake of Postpartum Intrauterine Device is 1581(5.4%) and female sterilization is 1830 (6.3%). In total 11387 mothers (52.2%) had the intention tochoose a postpartum family planning method. However, 36% of mothers neither used nor had theintention to choose a postpartum family planning method. Conclusions: The coverage of Postpartum Intrauterine Device counseling service coverage in Nepal ishigher in 2018 as compared to 2016-2017 and in other countries implementing Postpartum IntrauterineDevice initiatives. However, the prevalence of service coverage of immediate Postpartum FamilyPlanning methods, mainly Postpartum Intrauterine Device in 2018 is lower in Nepal as compared to2016-2017, and other countries implementing Postpartum Intrauterine Device initiative. More effortsare needed to encourage mothers delivering in the facilities to use the postpartum family planningmethod.

scholarly journals Clinical performance of intrauterine device TCu-380 A in Benghazi, Libyan Arab Jamahiriya

2000 ◽  
Vol 6 (5-6) ◽  
pp. 1073-1082
Author(s):  
R. Singh ◽  
M. Al Amari
Keyword(s):  
Clinical Performance ◽  
Intrauterine Device ◽  
Health Profile ◽  
Normal Delivery ◽  
Contraceptive Devices ◽  
Effectiveness Rate ◽  
Intrauterine Contraceptive ◽  
Using Data ◽  
Intrauterine Contraceptive Devices

The study examined the reproductive and health profile of Benghazi women using intrauterine contraceptive devices [IUDs]and evaluated one such device, the TCu-380 A. An historical longitudinal study was carried out using data from the Fertility Regulation Clinic, Keish Polyclinic, Benghazi. The subjects were 457 women registered for TCu-380 A insertion between 1995 and 1998, who had been under follow-up for at least 6 months. The majority were Libyan [87.8%], aged 20-29 years [63.4%], of parity 1-6 [67.1%], non-lactating [64.3%]and with normal delivery at last conception [95.1%]. Half had a chronic disease. The cumulative 36-month follow-up of those using TCu-380 A revealed an effectiveness rate of 99.8%, a continuation rate of 96.1% and complications in 3.5%. TCu-380 A appears to be an effective, durable and safe IUD.

Demography as Diplomacy

2021 ◽  
pp. 127-157
Author(s):  
Emily Klancher Merchant
Keyword(s):  
Developing Countries ◽  
Family Planning ◽  
Intrauterine Device ◽  
Unmet Need ◽  
Family Planning Programs ◽  
The Social ◽  
Philanthropic Organizations ◽  
Heads Of State ◽  
Development Agendas ◽  
And Training

Chapter 5 demonstrates how, in the 1950s and 1960s, U.S.-based philanthropic organizations invested in the growth of demography, the social science of human population dynamics, and used demography to convince heads of state of developing countries to integrate family planning programs into their nation-building and economic development agendas. The Population Council and the Ford Foundation established population research and training centers at major U.S. universities, to which they recruited graduate students from developing countries, with the understanding that they would return home after completing their education to advocate for the establishment of family planning programs. These organizations also funded fertility surveys by American demographers in Africa, Asia, and Latin America that promoted small-family norms and the distribution of new systemic contraceptive technologies, specifically the intrauterine device and birth control pill, and documented the existence of what demographers termed “unmet need” for family planning services.

scholarly journals 1088. Ultrasensitive Detection of C. difficile Toxins in Stool Using Single Molecule Counting Technology: A Multicenter Study for Evaluation of Clinical Performance

2018 ◽  
Vol 5 (suppl_1) ◽  
pp. S325-S326 ◽  
Author(s):  
Stephen Young ◽  
Ray Mills ◽  
Christen Griego-Fullbright ◽  
Aaron Wagner ◽  
Emily Herding ◽  
...  
Keyword(s):  
Single Molecule ◽  
Multicenter Study ◽  
Clinical Performance ◽  
Turnaround Time ◽  
Neutralization Assay ◽  
Single Step ◽  
Reporting Structure ◽  
One Step ◽  
Automated Immunoassay ◽  
Higher Sensitivity

Abstract Background Commercially available tests for Clostridium difficile infection (CDI) make test selection by the laboratory difficult due to the following unsatisfactory characteristics: long turnaround time, poor sensitivity, and/or poor specificity. The Singulex Clarity® C. diff toxins A/B assay (in development) is a rapid and automated immunoassay for the detection of C. difficile toxins A and B in stool, with analytical limits of detection for toxins A and B at 2.0 and 0.7 pg/mL, respectively. In this multicenter study, the clinical performance of the Singulex Clarity C. diff toxins A/B assay was compared with standalone PCR, a multistep algorithm with enzyme immunoassay (EIA) and PCR, and cell cytotoxicity neutralization assay (CCNA). Methods Fresh samples from 267 subjects with suspected CDI were tested at two sites (Minneapolis Medical Research Foundation and TriCore Reference Laboratories) with the Singulex Clarity assay, PCR (Xpert®C. difficile), and EIA (C. Diff Quik Chek Complete®) for GDH and toxin testing. The performance of the assays and multistep algorithms were evaluated against CCNA (Microbiology Specialists, Inc.). Results The overall CDI prevalence was 15.7%. The Singulex Clarity C. diff toxins A/B assay had 90.5% sensitivity and 96.0% specificity, with a 98.2% negative predictive value when compared with CCNA, and the Clarity assay’s AuROC was 0.9534. PCR had 90.5% sensitivity and 91.1% specificity. Compared with CCNA, the toxin EIA had 47.6% sensitivity and 100% specificity. Testing with a multistep algorithm using EIA with discordant results reflexed to PCR resulted in 85.7% sensitivity and 94.7% specificity. Conclusion The ultrasensitive Singulex Clarity C. diff toxins A/B assay is equivalent to the sensitivity of PCR while providing higher specificity. Compared with a multistep algorithm, the Clarity assay provides higher sensitivity and specificity while providing faster time-to-result in a simpler-to-understand, one-step reporting structure, allowing for a standalone, single-step solution for detection of C. difficile toxins in patients with suspected CDI. Disclosures E. Friedland, Singulex, Inc.: Employee, Salary. A. Bartolome, Singulex, Inc.: Employee, Salary. A. Almazan, Singulex, Inc.: Employee, Salary. S. Tam, Singulex, Inc.: Employee, Salary. S. Biscocho, Singulex, Inc.: Employee, Salary. S. Abusali, Singulex, Inc.: Employee, Salary. J. Sandlund, Singulex, Inc.: Employee, Salary. J. Estis, Singulex, Inc.: Employee, Salary. J. Bishop, Singulex, Inc.: Employee, Salary.

Sign in / Sign up

Export Citation Format

Share Document